{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T10:48:03Z","timestamp":1770547683401,"version":"3.49.0"},"reference-count":78,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1995,4]]},"DOI":"10.1212\/wnl.45.4.649","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:15:41Z","timestamp":1336914941000},"page":"649-658","update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":103,"title":["Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction"],"prefix":"10.1212","volume":"45","author":[{"given":"M. A.","family":"Sloan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.R.","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. K.","family":"Petito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. M. Y.","family":"Randall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. E.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. L.","family":"Terrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Collen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Kleiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Feit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Babb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Herman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. C.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Sopko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Bovill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Forman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. L.","family":"Knatterud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"3","volume":"1","year":"1986","unstructured":"Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-402.","journal-title":"Lancet"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.302.6767.1"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198601023140101"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(87)80074-8"},{"key":"e_1_3_1_6_2","first-page":"3","volume":"2","year":"1988","unstructured":"ISIS-2 (Second International Study of Infarct Survival). Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349-360.","journal-title":"Lancet"},{"key":"e_1_3_1_7_2","first-page":"6","volume":"336","year":"1990","unstructured":"Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-2. A factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet 1990;336:65-71.","journal-title":"Lancet"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91518-F"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199207023270101"},{"key":"e_1_3_1_10_2","first-page":"7","volume":"339","year":"1992","unstructured":"ISIS-3. A randomized comparison of streptokinase versus tissue plasminogen activator versus anistreplase and of aspirin plus heparin versus aspirin alone among 41,299 cases of suspected acute myocardial infarctions. ISIS-3 (Third International Study of Infarct Survival) Collaborative Group. Lancet 1992;339:753-770.","journal-title":"Lancet"},{"key":"e_1_3_1_11_2","first-page":"2","volume":"20","year":"1992","unstructured":"de Jaegere PP, Arnold AP, Balk AH, Simoons ML. Intracranial hemorrhage in association with thrombolytic therapy: incidence and clinical predictive factors. J Am Coll Cardiol 1992;20:289-294.","journal-title":"J Am Coll Cardiol"},{"key":"e_1_3_1_12_2","first-page":"5","volume":"24","year":"1993","unstructured":"Longstreth WT, Litwin PE, Weaver WD, for the MITI Project Group. Myocardial infarction, thrombolytic therapy, and stroke: a community-based study. Stroke 1993;24:587-590.","journal-title":"Stroke"},{"key":"e_1_3_1_13_2","first-page":"6","volume":"329","year":"1993","unstructured":"GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-682.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_14_2","first-page":"5","volume":"181","year":"1991","unstructured":"Uglietta JP, O'Connor CM, Boyko CB, Aldrich H, Massey EW, Heinz ER. CT patterns of intracranial hemorrhage complicating thrombolytic therapy for acute myocardial infarction. Radiology 1991;181:555-559.","journal-title":"Radiology"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(91)90850-K"},{"key":"e_1_3_1_16_2","first-page":"3","volume":"92","year":"1992","unstructured":"Kase CS, Pessin MS, Zivin JA, et al. Intracranial hemorrhage following thrombolysis with tissue plasminogen activator. Am J Med 1992;92:384-390.","journal-title":"Am J Med"},{"key":"e_1_3_1_17_2","first-page":"4","volume":"83","year":"1991","unstructured":"Gore JM, Sloan M, Price TR, et al, and the TIMI Investigators. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the thrombolysis in myocardial infarction study. Thrombolysis in Myocardial Infarction, Phase II, Pilot and Clinical Trial. Circulation 1991;83:448-459.","journal-title":"Circulation"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.67.1.1"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91879-Q"},{"key":"e_1_3_1_20_2","doi-asserted-by":"crossref","unstructured":"Passamani E Hodges M Herman M et al for the TIMI Investigators. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Pilot Study: tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1987;10(suppl):51B-64B.","DOI":"10.1016\/S0735-1097(87)80429-1"},{"key":"e_1_3_1_21_2","first-page":"2","volume":"260","year":"1988","unstructured":"TIMI Research Group. Immediate versus delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction: TIMI IIA results. JAMA 1988;260:2849-2858.","journal-title":"JAMA"},{"key":"e_1_3_1_22_2","first-page":"6","volume":"320","year":"1989","unstructured":"TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II Trial. N Engl J Med 1989;320:618-627.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_23_2","doi-asserted-by":"crossref","unstructured":"Braunwald E Knatterud G Passamani ER Robertson TL. Announcement of protocol change in Thrombolysis in Myocardial Infarction Trial (letter). J Am Coll Cardiol 1987;9: 467.","DOI":"10.1016\/S0735-1097(87)80407-2"},{"key":"e_1_3_1_24_2","first-page":"4","volume":"9","year":"1987","unstructured":"Grossbard EB. Genentech experience with rt-PA (Activaser) (letter). J Am Coll Cardiol 1987;9:467.","journal-title":"J Am Coll Cardiol"},{"key":"e_1_3_1_25_2","first-page":"9","volume":"10","year":"1987","unstructured":"Braunwald E, Knatterud G, Passamani ER, Robertson TL, Solomon R. Update from the Thrombolysis in Myocardial Infarction trial (letter). J Am Coll Cardiol 1987;10:970.","journal-title":"J Am Coll Cardiol"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410010102"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.32.1.1"},{"key":"e_1_3_1_28_2","first-page":"2","volume":"57","year":"1987","unstructured":"Kitamoto T, Ogomori K, Tateishi J, Prusiner SB. Methods in laboratory investigation: formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. Lab Invest 1987;57:230-236.","journal-title":"Lab Invest"},{"key":"e_1_3_1_29_2","first-page":"5","volume":"29","year":"1981","unstructured":"Hsu S, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. A comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-580.","journal-title":"J Histochem Cytochem"},{"key":"e_1_3_1_30_2","first-page":"1","volume":"42","year":"1985","unstructured":"Khachaturian ZS. The diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_31_2","first-page":"1","volume":"117","year":"1993","unstructured":"Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease. Arch Pathol Lab Med 1993;117:132-144.","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(81)90405-1"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(84)90674-X"},{"key":"e_1_3_1_34_2","first-page":"8","volume":"1","year":"1989","unstructured":"PRIMI Trial Study Group. Randomized double-blind trial of recombinant prourokinase against streptokinase in acute myocardial infarction. Lancet 1989;1:863-868.","journal-title":"Lancet"},{"key":"e_1_3_1_35_2","first-page":"2","volume":"1","year":"1988","unstructured":"National Heart Foundation of Australia Coronary Thrombolysis Group. Coronary thrombolysis and myocardial salvage by tissue plasminogen activator given up to four hours after onset of a myocardial infarction. Lancet 1988;1:203-208.","journal-title":"Lancet"},{"key":"e_1_3_1_36_2","first-page":"5","volume":"12","year":"1988","unstructured":"Neuhaus K-L, Tebbe U, Gottwik M, et al. Intravenous recombinant tissue plasminogen activator (rt-PA) and urokinase in acute myocardial infarction: results of the German Activator Urokinase Study (GAUS). J Am Coll Cardiol 1988;12:581-587.","journal-title":"J Am Coll Cardiol"},{"key":"e_1_3_1_37_2","first-page":"3","volume":"85","year":"1988","unstructured":"Califf RM, Topol EJ, George BS, et al, and the Thrombolysis and Angioplasty in Myocardial Infarction Study Group. Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction. Am J Med 1988;85:353-359.","journal-title":"Am J Med"},{"key":"e_1_3_1_38_2","first-page":"5","volume":"1","year":"1988","unstructured":"AIMS Trial Study Group. Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1988;1:545-549.","journal-title":"Lancet"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)90135-R"},{"key":"e_1_3_1_40_2","first-page":"1","volume":"47","year":"1990","unstructured":"Proner J, Rosenblum BR, Rothman A. Ruptured arteriovenous malformation complicating thrombolytic therapy with tissue plasminogen activator. Arch Neurol 1990;47:105-106.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_41_2","first-page":"2","volume":"29","year":"1991","unstructured":"Pendlebury WW, Iole ED, Tracy RP, Dill BA. Intracerebral hemorrhage related to cerebral amyloid angiopathy and t-PA treatment. Ann Neurol 1991;29:210-213.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_42_2","first-page":"3","volume":"17","year":"1990","unstructured":"Ramsay DA, Penswick JL, Robertson DM. Fatal streptokinase-induced intracerebral hemorrhage in cerebral amyloid angiopathy. Can J Neurol Sci 1990;17:336-341.","journal-title":"Can J Neurol Sci"},{"key":"e_1_3_1_43_2","first-page":"5","volume":"24","year":"1993","unstructured":"Wijdicks CFM, Jack CR. Intracerebral hemorrhage after fibrinolytic therapy for acute myocardial infarction. Stroke 1993;24:554-557.","journal-title":"Stroke"},{"key":"e_1_3_1_44_2","first-page":"3","volume":"57","year":"1987","unstructured":"Eisenberg PR, Sherman LA, Tiefenbrunn AJ, Ludbrook PA, Sobel BE, Jaffe AS. Sustained fibrinolysis after administration of t-PA despite its short half life in the circulation. Thromb Haemost 1987;57:35-40.","journal-title":"Thromb Haemost"},{"key":"e_1_3_1_45_2","first-page":"2","volume":"171","year":"1987","unstructured":"Gorelick PB, Parikh M, McDonald L. Intracoronary streptokinase and fatal cerebellar hemorrhage. IMJ 1987;171:28-32.","journal-title":"IMJ"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410080102"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.17.1.1"},{"key":"e_1_3_1_48_2","first-page":"5","volume":"18","year":"1987","unstructured":"Bahemuka M. Primary intracerebral hemorrhage and heart weight: a clinicopathologic case-control review of 218 patients. Stroke 1987;18:531-536.","journal-title":"Stroke"},{"key":"e_1_3_1_49_2","first-page":"9","volume":"35","year":"1985","unstructured":"Kase CS, Robinson RK, Stein RW, et al. Anticoagulant-related intracerebral hemorrhage. Neurology 1985;35:943-948.","journal-title":"Neurology"},{"key":"e_1_3_1_50_2","first-page":"3","volume":"7","year":"1977","unstructured":"Snyder M, Renaudin J. Intracerebral hemorrhage associated with anticoagulation therapy. Surg Neurol 1977;7:31-34.","journal-title":"Surg Neurol"},{"key":"e_1_3_1_51_2","first-page":"3","volume":"133","year":"1974","unstructured":"Coon WW, Willis PW. Hemorrhagic complications of anticoagulant therapy. Arch Intern Med 1974;133:386-392.","journal-title":"Arch Intern Med"},{"key":"e_1_3_1_52_2","first-page":"6","volume":"38","year":"1988","unstructured":"Caplan L. Intracerebral hemorrhage revisited. Neurology 1988;38:624-627.","journal-title":"Neurology"},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-113-1-9"},{"key":"e_1_3_1_54_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-113-1-9"},{"key":"e_1_3_1_55_2","first-page":"9","volume":"4","year":"1973","unstructured":"McCormick WF, Rosenfield DB. Massive brain hemorrhage: a review of 144 cases and an examination of their causes. Stroke 1973;4:946-954.","journal-title":"Stroke"},{"key":"e_1_3_1_56_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.31.1.8"},{"key":"e_1_3_1_57_2","first-page":"5","volume":"40","year":"1983","unstructured":"Hickey WF, King RB, Wang AM, Samuels MA. Multiple simultaneous intracerebral hematomas: clinical, radiologic, and pathologic findings in two patients. Arch Neurol 1983;40:519-522.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_58_2","first-page":"6","volume":"30","year":"1991","unstructured":"Vonsattel JPG, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histologic study. Ann Neurol 1991;30:637-649.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_59_2","first-page":"3","volume":"16","year":"1984","unstructured":"Kalyan-Raman UP, Kalyan-Raman K. Cerebral amyloid angiopathy causing intracranial hemorrhage. Ann Neurol 1984;16:321-329.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_60_2","first-page":"3","volume":"18","year":"1987","unstructured":"Vinters HV. Cerebral amyloid angiopathy: a critical review. Stroke 1987;18:311-323.","journal-title":"Stroke"},{"key":"e_1_3_1_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(93)90081-9"},{"key":"e_1_3_1_62_2","first-page":"5","volume":"31","year":"1992","unstructured":"Leblanc R, Haddad G, Robitaille Y. Cerebral hemorrhage from amyloid angiopathy after coronary thrombolysis. Neurosurgery 1992;31:586-590.","journal-title":"Neurosurgery"},{"key":"e_1_3_1_63_2","first-page":"3","volume":"11","year":"1991","unstructured":"Sloan MA, Price TR. Intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction. Semin Neurol 1991;11:385-399.","journal-title":"Semin Neurol"},{"key":"e_1_3_1_64_2","first-page":"2","volume":"69","year":"1992","unstructured":"Sloan MA, Gore JM. Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: a risk-benefit analysis. In: Gore JM, Becker RC, eds. A symposium: safety of thrombolytic agents. Am J Cardiol 1992;69:21A-38A.","journal-title":"Am J Cardiol"},{"key":"e_1_3_1_65_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410320703"},{"key":"e_1_3_1_66_2","first-page":"6","volume":"8","year":"1963","unstructured":"Mutlu N, Berry RG, Alpers BJ. Massive cerebral hemorrhage: clinical and pathological correlations. Arch Neurol 1963;8:644-661.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_67_2","first-page":"8","volume":"41","year":"1991","unstructured":"Bogousslavsky J, Regli F, Uske A, Maeder P. Early spontaneous hematoma in cerebral infarct: is primary cerebral hemorrhage overdiagnosed? Neurology 1991;41:837-840.","journal-title":"Early spontaneous hematoma in cerebral infarct: is primary cerebral hemorrhage overdiagnosed? Neurology"},{"key":"e_1_3_1_68_2","first-page":"9","volume":"110","year":"1987","unstructured":"Laureno R, Shields PW, Narayan T. The diagnosis and management of cerebral embolism and haemorrhagic infarction with sequential computerized cranial tomography. Brain 1987;110:93-105.","journal-title":"Brain"},{"key":"e_1_3_1_69_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.19.1.1"},{"key":"e_1_3_1_70_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.297.6640.1"},{"key":"e_1_3_1_71_2","first-page":"1","volume":"45","year":"1988","unstructured":"Carlson S, Aldrich MS, Greenberg HS, Topol EJ. Intracerebral hemorrhage complicating intravenous tissue plasminogen activator treatment. Arch Neurol 1988;45:1070-1073.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_72_2","first-page":"9","volume":"30","year":"1992","unstructured":"Da Silva VF, Bormanis J. Intracerebral hemorrhage after combined anticoagulant-thrombolytic therapy for myocardial infarction: two case reports and a short review. Neurosurgery 1992;30:943-945.","journal-title":"Neurosurgery"},{"key":"e_1_3_1_73_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-1-1"},{"key":"e_1_3_1_74_2","first-page":"2","volume":"115","year":"1991","unstructured":"Bovill EG, Terrin ML, Stump DC, et al, for the TIMI Investigators. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Ann Intern Med 1991;115:256-265.","journal-title":"Ann Intern Med"},{"key":"e_1_3_1_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91872-J"},{"key":"e_1_3_1_76_2","unstructured":"Kase CS Mohr JP. General features of intracerebral hemorrhage. In: Barnett HJH Mohr JP Stein BM Yatsu FM eds. Stroke pathophysiology diagnosis and management. New York: Churchill Livingstone 1986:497-523."},{"key":"e_1_3_1_77_2","first-page":"9","volume":"50","year":"1987","unstructured":"Portenoy RK, Lipton RB, Berger AR, Lesser ML, Lantos G. Intracerebral hemorrhage: a model for the prediction of outcome. J Neurol Neurosurg Psychiatry 1987;50:976-979.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"e_1_3_1_78_2","first-page":"2","volume":"24","year":"1988","unstructured":"Tuhrim S, Dambrosia JM, Price TR, et al. Prediction of intracerebral hemorrhage outcome. Ann Neurol 1988;24:258-263.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_79_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410290104"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.45.4.649","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T15:59:55Z","timestamp":1711641595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.45.4.649"}},"subtitle":["The Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial Combined experience"],"short-title":[],"issued":{"date-parts":[[1995,4]]},"references-count":78,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,4]]}},"alternative-id":["10.1212\/WNL.45.4.649"],"URL":"https:\/\/doi.org\/10.1212\/wnl.45.4.649","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,4]]}}}